Instruments

Name Stock exchange Average volume Price Type
CHARLES SCHWAB SCHW34

Sao Paulo

2,488 50.5 BRL Stock Charles Schwab Stock
CHARLES SCHWAB SCHW

Nyse +9 Other

6,287,670 78.78 USD Stock Charles Schwab Stock
CHARLES SCHWAB SWG

Deutsche Boerse AG

7 72.09 EUR Stock Charles Schwab
CHARLES SCHWAB 0L3I

London S.E.

130,190 78.3 USD Stock Charles Schwab
CHARLES SCHWAB CORPORATION (THE) 0L3I

CINNOBER BOAT

- - USD Stock Charles Schwab Corporation (The)
CHARLES SCHWAB SWG

Börse Stuttgart

8 72.33 EUR Stock Charles Schwab
THE CHARLES SCHWAB CORPORATION SCHW

Wiener Boerse

- 72.29 EUR Stock The Charles Schwab Corporation
THE CHARLES SCHWAB CORPORATION SCHW *

Mexican S.E.

112 1,276 MXN Stock The Charles Schwab Corporation
CHARLES SCHWAB SWG

BOERSE MUENCHEN

82 72.75 EUR Stock Charles Schwab
CHARLES SCHWAB SWG

Frankfurt

0 51.45 EUR Stock Charles Schwab
THE CHARLES SCHWAB CORPORATION

Berne S.E.

- 65.01 CHF Stock The Charles Schwab Corporation
CHARLES SCHWAB SCHW.PRD

Nyse

31,108 24.91 USD Stock Charles Schwab Stock
CHARLES SCHWAB SCHW.PRJ

Nyse +1 Other

35,851 20 USD Stock Charles Schwab Stock
CHARLES SCHWAB SWG0

Deutsche Boerse AG

- 18.1 EUR Stock Charles Schwab
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL

Nyse +6 Other

580,434 221.6 USD Stock Charles River Laboratories International, Inc. Stock
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. RV6

Deutsche Boerse AG

- 206.3 EUR Stock Charles River Laboratories International, Inc.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. RV6

Börse Stuttgart

- 203 EUR Stock Charles River Laboratories International, Inc.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. RV6

BOERSE MUENCHEN

- 203.9 EUR Stock Charles River Laboratories International, Inc.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. RV6

Frankfurt

- 215.8 EUR Stock Charles River Laboratories International, Inc.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL *

Mexican S.E.

1,250 4,049 MXN Stock Charles River Laboratories International, Inc.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. RV6

Berne S.E.

- - CHF Stock Charles River Laboratories International, Inc.
CHARLES & COLVARD, LTD. CTHR

Nasdaq +1 Other

22,702 2.6 USD Stock Charles & Colvard, Ltd. Stock
CHARLES & COLVARD, LTD. CDR

Deutsche Boerse AG

- 1.98 EUR Stock Charles & Colvard, Ltd.
MAC CHARLES (INDIA) LIMITED MCCHRLS-B

Bombay S.E.

249 444 INR Stock Mac Charles (India) Limited Stock
CHARLES SCHWAB

Deutsche Boerse AG

- 93.52 % Bond Charles Schwab Bond
CHARLES SCHWAB

Deutsche Boerse AG

- 95.05 % Bond Charles Schwab Bond
CHARLES SCHWAB

Börse Stuttgart

- 93.38 % Bond Charles Schwab Bond

News (52)

Spin Master Corp. Announces Election of Directors PR
Transcript : Spin Master Corp. - Shareholder/Analyst Call
Spin Master Corp. Announces Election of Directors PR
Spin Master Corp. Announces Election of Directors AQ
Transcript : Spin Master Corp. - Shareholder/Analyst Call
TMX Group to appoint Luc Bertrand as Chair of the Board AQ
Luc Bertrand to helm board of TMX Group, replacing Charles Winograd AQ
TMX Group to appoint Luc Bertrand as Chair of the Board AQ
TMX Group Limited Announces Resignation of Charles Winograd from Board CI
LAVA Therapeutics Announces the Appointment of Dr. Charles Morris as Chief Medical Officer GL
LAVA Therapeutics N.V. Announces the Appointment of Dr. Charles Morris as Chief Medical Officer CI
LAVA Therapeutics Announces the Appointment of Dr. Charles Morris as Chief Medical Officer GL
Spin Master Corp. Announces Election of Directors PR
TMX Group Announces Election of Directors AQ
Transcript : TMX Group Limited - Shareholder/Analyst Call
TMX : Announces Election of Directors AQ
Transcript : TMX Group Limited - Shareholder/Analyst Call
Spin Master Corp. : Announces Election of Directors PR
Transcript : Spin Master Corp. - Shareholder/Analyst Call
Fed will be tested in 2021 as vaccines boost U.S. economic outlook RE
Fed will be tested in 2021 as vaccines boost U.S. economic outlook RE
TMX : Adds Two New Directors to its Board AQ
TMX : Le Groupe TMX ajoute deux nouveaux administrateurs à son conseil d’administration PU
TMX : Names John McKenzie as new Chief Executive Officer AQ
TMX : Announces Election of Directors AQ
Transcript : TMX Group Limited - Shareholder/Analyst Call
Spin Master : Announces Election of Directors AQ
Transcript : Spin Master Corp. - Shareholder/Analyst Call
TMX : Lou Eccleston to Retire From TMX Group AQ
TMX : Lou Eccleston to Retire From TMX Group AQ
National Academy of Arbitrators : Elects Officers; Daniel J. Nielsen Named President-Elect BU
Spin Master Corp. : Announces Election of Directors PR
TMX : Le Groupe TMX annonce l’élection de ses administrateurs PU
Transcript : TMX Group Limited - Shareholder/Analyst Call
Spin Master Corp. : Announces Election of Directors PR
RioCan Real Estate Investment Trust : Announces Results of Voting at RioCan's Annual Meeting MW
Spin Master Corp. : Announces Election of Directors PR
Transcript : TMX Group Limited - Shareholder/Analyst Call
RioCan Real Estate Investment Trust : Announces Results of Its Review of the Trust's Executive Compensation Practices MW
RioCan Real Estate Investment Trust : Announces Results of Voting at RioCan's Annual Meeting MW
Spin Master Corp. : Announces Election of Directors PR
Transcript : TMX Group Limited - Shareholder/Analyst Call
RioCan Real Estate Investment Trust : Announces Results of Voting at RioCan's Annual and Special Meeting MW
Transcript : TMX Group Limited - Shareholder/Analyst Call
Nuance Communications : Announces the Winograd Schema Challenge to Advance Artificial Intelligence Innovation BU
12NextSee all

Companies (41)

CHARLES SCHWAB 144 B $
Logo Charles Schwab

The Charles Schwab Corporation specializes in brokerage and banking services. Net sales break down by activity as follows: - brokerage and banking services to individual investors (73.6%); - investment services to institutional investors (26.4%). Beside ...

CHARLES SCHWAB 144 B $
Logo Charles Schwab

The Charles Schwab Corporation specializes in brokerage and banking services. Net sales break down by activity as follows: - brokerage and banking services to individual investors (73.6%); - investment services to institutional investors (26.4%). Beside ...

CHARLES SCHWAB 144 B $
Logo Charles Schwab

The Charles Schwab Corporation specializes in brokerage and banking services. Net sales break down by activity as follows: - brokerage and banking services to individual investors (73.6%); - investment services to institutional investors (26.4%). Beside ...

CHARLES SCHWAB 144 B $
Logo Charles Schwab

The Charles Schwab Corporation specializes in brokerage and banking services. Net sales break down by activity as follows: - brokerage and banking services to individual investors (73.6%); - investment services to institutional investors (26.4%). Beside ...

ENERGY TRANSFER LP 53 786 M $
Logo Energy Transfer LP

Energy Transfer LP owns and operates a diversified portfolios of energy assets in the United States. The Company is engaged in natural gas operations such as natural gas midstream and intrastate transportation and storage, and interstate natural gas trans ...

ENERGY TRANSFER LP 53 786 M $
Logo Energy Transfer LP

Energy Transfer LP owns and operates a diversified portfolios of energy assets in the United States. The Company is engaged in natural gas operations such as natural gas midstream and intrastate transportation and storage, and interstate natural gas trans ...

GAMING AND LEISURE PROPERTIES, INC. 12 500 M $
Logo Gaming and Leisure Properties, Inc.

Gaming and Leisure Properties, Inc. is a self-administered and self-managed Pennsylvania real estate investment trust. The Company's primary business consists of acquiring, financing, and owning real estate property to be leased to gaming operators in tri ...

AÉROPORTS DE PARIS 13 617 M $
Logo Aéroports de Paris

Aéroports de Paris develops and manages airports, including Paris-Charles de Gaulle, Paris-Orly and Paris-Le Bourget. In 2023, the Group handled c. 99.7 million passengers at Paris-CDG and Paris-Orly, and c. 326.7 million passengers abroad. Boasting an ex ...

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 11 416 M $
Logo Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. specializes in the development of products and services in the field of research and non-clinical drug development for pharmaceutical companies, government agencies and academic institutions. Net sales break ...

PERSIMMON PLC 5 971 M $
Logo Persimmon Plc

Persimmon Plc is the leading British real estate constructor. In 2022, the group sold 14,868 homes, broken down into traditional family housing (11,282; Persimmon), affordable social housing (2,694; Westbury Partnerships) and individual homes (892; Charl ...


1234Next

Insiders

Picture Charles Winograd
Charles Winograd

Charles M. Winograd is a businessperson who founded Elm Park Capital Management LLC and who has been at the head of 8 different companies. Currently, he holds the position of Chairman at TMX Group Ltd., Chairman for TMX Group, Inc. (a subsidiary of TMX Group Ltd.) and President of Winograd Capital, Inc. Charles M. Winograd is also Senior Managing Partner at Elm Park Credit Opportunities Fund LP and Senior Managing Partner at Elm Park Capital Management LLC and on the board of 10 other companies. In his past career Mr. Winograd was Director at Tamir Fishman & Co. Ltd., Head-Capital Markets at Royal Bank of Canada Chairman & Chief Executive Officer at Richardson Greenshields of Canada Ltd. President & Chief Executive Officer for RBC Dominion Securities, Inc. Chief Executive Officer of RBC Capital Markets LLC and Principal at RBC Capital Markets LLC (Investment Management) (which are all subsidiaries of Royal Bank of Canada) and Chairman for Investment Dealers Association of Canada. Charles M. Winograd received an undergraduate degree from the University of Manitoba and an MBA from Richard Ivey School of Business.


Picture Randy Winograd
Randy Winograd

Mr. Randy Winograd is Chief Operating Officer at Nimes Capital LLC.
Prior to joining Nimes Capital, he was President and General Counsel of Nazarian Enterprises' affiliate, sbe, which he joined in 2004 as sbe's founding CFO and General Counsel.
At sbe, Mr. Winograd was instrumental in managing the growth of the company from a nascent venture into a hospitality powerhouse and played a key role in the strategizing, structuring and oversight of more than $2 billion in projects.
Before joining sbe, Mr. Winograd was Chief Operating Officer, CFO and General Counsel of a prominent production company where he deftly managed the business, financial and legal affairs of entities that generated in excess of $150 million in annual revenue.
Mr. Winograd began his professional career as an associate in the Los Angeles law offices of Pillsbury, Madison & Sutro, with a practice focusing on commercial litigation.
He is a past Director of the Motion Picture Industry Pension and Health Plans (multi-employer benefit plans with approximately $4 billion in assets) and of Film L.A., Inc. where he also served as its Treasurer and Chairman of its Finance Committee.
Mr. Winograd earned a Juris Doctor from the University of Michigan Law School in 1994 and a Bachelor of Business Administration, with High Distinction, with a concentration in Finance from the University of Michigan's Stephen M.
Ross School of Business in 1991.


Picture Brad Winograd
Brad Winograd

Mr. Brad Winograd, CPA, is on the Board of Directors at Jetscape, Inc. Mr. Winograd was previously employed as Finance Director by International Lease Finance Corp., Auditor by Ernst & Young LLP (Missouri), and President & Chief Financial Officer by Indigo Aviation AB.
He received his undergraduate degree from the University of California, Berkeley.





Picture Benjamin Winograd
Benjamin Winograd

Benjamin Winograd worked as an Executive Director-Clinical Oncology at Bristol Myers Squibb Co. from 1990 to 1999.
He then worked as Vice President-Global Medical Affairs & Oncology at Schering-Plough Biopharma from 2004 to 2007.
From 2007 to 2020, he worked at Celgene Corp.
as Head-Clinical R&D Therapeutic Area.
Currently, he is the Chief Medical Officer at LAVA Therapeutics NV, a position he started in 2020 and will hold until 2023.
Dr. Winograd received his graduate and doctorate degrees from Technische Universität München.


No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW